Literature DB >> 15139109

[Comparative studies on pharmacological effects of angong niuhuang pill with its simplified prescicription].

Zu-guang Ye1, Jin-hua Wang, Ai-hua Liang, Bao-yun Xue, Yue-sheng Wang, Zhi-min Wang, Lan Wang, Chun-ying Li, Jing Zhang, Ning Huang, Ai-ying Jin.   

Abstract

OBJECTIVE: Based on the therapeutic claims of Angong Niuhuang pill, a series of pharmacodynamic experiments were designed, where pharmacological effects were investigated comparatively with its simplified prescription(realgar and cinnabar are removed from the original pill) as a parallel control in order to explore possible contribution of cinnabar and realgar to pharmacodynamic activities of the pill as a whole.
METHOD: Anti-pyretic, sedative, anti-convulsive, and mice-protected effects of the pill and its simplified prescription as a control were observed, respectively, in rabbits with fever induced by typhoid bacillus, in pentobarbital sodium-induced sleeping mice, in mice with convulsion induced by strychnine, or pentylenetetrazole, and in mice with anoxia induced by NaNO2. RESULT: Both the pill and its simplified prescription were found to have Anti-pyretic action and protective effect against the mouse death induced by anoxia, and synergistic interaction with pentobarbital sodium in sedative activity, although neither of them was found to have any effects on the convulsion of mice.
CONCLUSION: No significant difference between Angong Niuhuang pill and its simplified prescription was found in the above pharmacodynamic experiments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15139109

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

Review 1.  Therapeutic effects of traditional herbal medicine on cerebral ischemia: a perspective of vascular protection.

Authors:  Youngmin Bu; Kyungjin Lee; Hyuk-Sang Jung; Sang-Kwan Moon
Journal:  Chin J Integr Med       Date:  2013-10-30       Impact factor: 1.978

Review 2.  Use of angong niuhuang in treating central nervous system diseases and related research.

Authors:  Yu Guo; Shaohua Yan; Lipeng Xu; Gexin Zhu; Xiaotong Yu; Xiaolin Tong
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-18       Impact factor: 2.629

Review 3.  Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China.

Authors:  Wei Zhuang; Zheng Fan; Yanqi Chu; Haizheng Wang; Ying Yang; Li Wu; Nan Sun; Ge Sun; Yuqiao Shen; Xiaolan Lin; Guiming Guo; Shengyan Xi
Journal:  Front Pharmacol       Date:  2020-07-17       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.